Download presentation
Presentation is loading. Please wait.
Published byFerdinand Nicholson Modified over 6 years ago
1
Apremilast in the treatment of moderate to severe hidradenitis suppurativa: A case series of 9 patients Patrizia Weber, MD, S. Morteza Seyed Jafari, MD, Nikhil Yawalkar, MD, Robert E. Hunger, MD, PhD Journal of the American Academy of Dermatology Volume 76, Issue 6, Pages (June 2017) DOI: /j.jaad Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions
2
Fig 1 Response to apremilast in patient 2 with gluteal hidradenitis suppurativa. A, Before therapy, erythema, edema, confluent nodules, multiple fistulae, and comedones are present. During therapy, a reduction in erythema, edema, and nodules was observed, though comedones, scars, and hyperpigmentation remained. B, After 2 months of therapy. C, After 8 months of therapy. D, After 9 months of therapy. Journal of the American Academy of Dermatology , DOI: ( /j.jaad ) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.